With new technologies that allow drugs to be tested directly in human biological systems, researchers are beginning to ...
Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...
An international team involving the Institute of Chemical Research, a joint center of the University of Seville and the ...
In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
MORE THAN $200 MILLION IN FEDERAL FUNDING IS HEADED TO NEW MEXICO FOR MILITARY AND COMMUNITY PROJECTS, TO. THE MONEY WAS ...
Lupin commissions oncology block at Vizag plant, expanding CDMO capabilities for high-potent APIs and oncology drug ...
The footprint of death (also referred to as FOOD in the study) may help guide the immune cells to the exact spot to clear ...
News-Medical.Net on MSN
New technique revolutionizes the design of drugs that target ion channels
An international team involving the Institute of Chemical Research, a joint centre of the University of Seville and the ...
Researchers at the University created an AI model called EZSpecificity to test how certain enzymes and substrates bind to ...
Innovation in drug development has never moved faster! New modalities, real-world evidence, complex patient stratification, and AI are reshaping what’s possible. Yet one of the biggest bottlenecks ...
Quality, stability, sustainability, and the increased and thoughtful integration of artificial intelligence are foremost in the minds of those on the leading edge of testing trends.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback